Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 272 No 7282 p48
17 January 2004

This article
Reprint
Photocopy


News summary

Related websites
Journal of Applied Toxicology abstract (more)


Debate over deodorant use and breast cancer reignited

Esters of p-hydroxybenzoic acid (parabens), which are used as preservatives in underarm deodorants and antiperspirants, can be detected in samples of tissue from human breast tumours, say researchers.

The finding has fuelled debate over whether these chemicals, which are thought to be oestrogenic, have contributed to the rising incidence of breast cancer. However, toxicologists have warned that no causal association has been found.

The latest research, published in the Journal of Applied Toxicology (2004;24:5), reveals that parabens accumulate in human breast tissue and that the levels measured could exert oestrogenic effects. However, the authors of an accompanying editorial (ibid, p1) write: “The detection of parabens in breast tumour tissue should not be taken to imply causality of the individual cancer, because the findings are essentially coincidental in nature.” They add that normal breast tissue, and other tissue, was not analysed.

Richard Sullivan, head of clinical programmes at Cancer Research UK, said: “No causal relationship has been found between underarm cosmetics containing parabens and breast cancer. There is also no robust population-based evidence to suggest a link.”

Back to Top


Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal